A detailed history of Janus Henderson Group PLC transactions in Johnson & Johnson stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,033,002 shares of JNJ stock, worth $172 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,033,002
Previous 987,156 4.64%
Holding current value
$172 Million
Previous $156 Million 3.31%
% of portfolio
0.08%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $6.62 Million - $7.23 Million
45,846 Added 4.64%
1,033,002 $151 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $49.3 Million - $51.7 Million
-317,853 Reduced 24.36%
987,156 $156 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $4.12 Million - $4.49 Million
-28,263 Reduced 2.12%
1,305,009 $205 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $3.87 Million - $4.33 Million
-24,826 Reduced 1.83%
1,333,272 $208 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $7.22 Million - $7.77 Million
-46,764 Reduced 3.33%
1,358,098 $225 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $14.7 Million - $17.6 Million
-97,626 Reduced 6.5%
1,404,862 $218 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $4.86 Million - $5.45 Million
-30,309 Reduced 1.98%
1,502,488 $265 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $67.5 Million - $75.1 Million
418,598 Added 37.57%
1,532,797 $251 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $74 Million - $81.8 Million
-440,010 Reduced 28.31%
1,114,199 $198 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $2.44 Million - $2.77 Million
15,414 Added 1.0%
1,554,209 $275 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $26.1 Million - $29 Million
-167,349 Reduced 9.81%
1,538,795 $263 Million
Q3 2021

Nov 16, 2021

SELL
$161.5 - $179.47 $54.5 Million - $60.6 Million
-337,390 Reduced 16.51%
1,706,144 $276 Million
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $20.8 Million - $22.3 Million
-130,503 Reduced 6.0%
2,043,534 $337 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $59.2 Million - $66 Million
-387,016 Reduced 15.11%
2,174,037 $357 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $56.6 Million - $64.9 Million
-412,540 Reduced 13.87%
2,561,053 $403 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $33 Million - $36.2 Million
-235,334 Reduced 7.33%
2,973,593 $443 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $40.2 Million - $48.5 Million
-312,067 Reduced 8.86%
3,208,927 $451 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $123 Million - $171 Million
-1,110,094 Reduced 23.97%
3,520,994 $462 Million
Q4 2019

Feb 18, 2020

BUY
$127.5 - $146.44 $38.2 Million - $43.8 Million
299,422 Added 6.91%
4,631,088 $675 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $43.8 Million - $49 Million
344,635 Added 8.64%
4,331,666 $560 Million
Q2 2019

Jul 31, 2019

SELL
$131.15 - $144.24 $17.4 Million - $19.1 Million
-132,443 Reduced 3.22%
3,987,031 $555 Million
Q1 2019

Apr 30, 2019

BUY
$125.72 - $139.79 $4.9 Million - $5.45 Million
38,958 Added 0.95%
4,119,474 $576 Million
Q4 2018

Feb 06, 2019

SELL
$122.84 - $147.84 $40.9 Million - $49.3 Million
-333,210 Reduced 7.55%
4,080,516 $527 Million
Q3 2018

Nov 09, 2018

SELL
$121.58 - $142.88 $57.2 Million - $67.2 Million
-470,272 Reduced 9.63%
4,413,726 $610 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $86.9 Million - $95.8 Million
727,411 Added 17.5%
4,883,998 $593 Million
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $16.3 Million - $19.3 Million
-130,270 Reduced 3.04%
4,156,587 $533 Million
Q4 2017

Feb 09, 2018

SELL
$131.22 - $143.62 $11.8 Million - $12.9 Million
-89,683 Reduced 2.05%
4,286,857 $599 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $81.4 Million - $85.1 Million
628,532 Added 16.77%
4,376,540 $0
Q2 2017

Aug 17, 2017

BUY
N/A
3,748,008
3,748,008 $496 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.